Key proteins discovered in tumour spread
2 Jan 2008
Scientists have unlocked the secrets of proteins involved in tumour cells creeping away from the original tumour and spreading around the body. Their findings are published in Molecular Cell.
The study involves a protein called Tes which appears to block cell growth and prevent tumours from forming. Scientists have now shown that it locks onto Mena – a protein involved in cell crawling that is found in excessive amounts in tumours.
This is exciting because Tes binds to Mena in an unexpected way compared with other proteins that interact with Mena.
Crucially, when Tes binds to Mena, it stops cells from crawling as it blocks Mena from sticking to its usual binding partners.
The discovery offers the possibility of the development of drugs which could block the action of Mena by mimicking the action of Tes.
The movement of cells from the primary tumour to other parts of the body is the main reason that cancer can be so difficult to treat. Preventing this is one of the major challenges for researchers.
Dr Michael Way, lead author based at Cancer Research UK’s London Research Institute, said: “Our findings represent a new way to regulate of a key family of proteins involved in cell crawling that will change the way researchers see current models of cell migration – an important aspect of the spread of cancer.”
Dr Lesley Walker, director of science information at Cancer Research UK, said: “Cancer cells use many complex processes when they break away from their tumour and spread to other areas of the body. Understanding these mechanisms and increasing our knowledge about this protein can hopefully help us to develop more effective cancer treatments in the future.”
Your donations help us do more
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.